|
Volumn 2, Issue 6, 2013, Pages
|
The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANTIINFLAMMATORY AGENT;
ANTIRHEUMATIC AGENT;
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
DRUG;
LIPID;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
PIOGLITAZONE;
ADULT;
AGED;
ARTERIAL STIFFNESS;
ARTICLE;
BLOOD;
BLOOD VESSEL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG POTENTIATION;
ELASTICITY;
FEMALE;
HUMAN;
INFLAMMATION;
MALE;
METABOLISM;
MIDDLE AGED;
PATHOPHYSIOLOGY;
PULSE WAVE;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
RHEUMATOID ARTHRITIS;
SEVERITY OF ILLNESS INDEX;
TIME;
TREATMENT OUTCOME;
UNITED STATES;
VASODILATATION;
DRUGS;
INFLAMMATION;
RHEUMATOID ARTHRITIS;
VASODILATION;
ADULT;
AGED;
ANTI-INFLAMMATORY AGENTS;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
BIOLOGICAL MARKERS;
BLOOD VESSELS;
C-REACTIVE PROTEIN;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
ELASTICITY;
FEMALE;
HUMANS;
LIPIDS;
MALE;
MICHIGAN;
MIDDLE AGED;
PPAR GAMMA;
PULSE WAVE ANALYSIS;
QUALITY OF LIFE;
QUESTIONNAIRES;
SEVERITY OF ILLNESS INDEX;
THIAZOLIDINEDIONES;
TIME FACTORS;
TREATMENT OUTCOME;
VASCULAR STIFFNESS;
VASODILATION;
|
EID: 84902300618
PISSN: None
EISSN: 20479980
Source Type: Journal
DOI: 10.1161/JAHA.113.000441 Document Type: Article |
Times cited : (61)
|
References (0)
|